Ms. Gessner has served as Poseida’s vice president, regulatory affairs since January 2017. She has over 25 years of hands-on regulatory and compliance experience. Previously, Ms. Gessner served as vice president, regulatory and quality affairs at Tocagen Inc. and Sirion Therapeutics. Prior to joining Sirion, she was director of regulatory affairs and quality assurance at Bruin Pharma and Santarus Inc. Gessner is a member of the Regulatory Affairs Professional Society (RAPS), Parental Drug Association (PDA) and American Society for Gene Therapy. She holds an M.Sc. in regulatory affairs from San Diego State University and a B.S. in medical technology from the University of Texas medical branch in Galveston.